READ MORE: Struggling mothers reveal the dark side of the 'miracle' ADHD drugSee more Daily Mail on Google - save us as a Preferred SourceBy LUKE ANDREWS, U.S. SENIOR HEALTH CORRESPONDENT Published: 20:51 BST, 15 June 2026 | Updated: 20:52 BST, 15 June 2026
Hundreds of thousands of bottles of a hugely popular antidepressant have been recalled over fears that they could contain a cancer-causing chemical.More than 370,000 bottles of duloxetine delayed-release capsules, sold by New Jersey-based Breckenridge Pharmaceuticals and commonly known as Cymbalta, were subject to the warning.The FDA raised the alarm after tests found the capsules contained higher than permitted levels of N-nitroso-duloxetine, which is considered to be a probable carcinogen to humans.No illnesses have been reported to date, but the agency warned this was a Class II recall, meaning exposure to the product could cause temporary or medically reversible events.The recall includes 360,000 bottles of 60 milligram (mg) capsules, sold in bottles containing 90 or 1,000 capsules.It also includes 14,000 bottles of 30mg capsules, sold in bottles containing 1,000 capsules. The prescription-only drugs were sold nationwide and have best-before dates up to May next year.No advice has been issued by officials on what to do if you have the recalled drugs at home, but, typically, people are advised to contact their doctors to seek alternatives. More than 370,000 bottles of duloxetine delayed-release capsules have been recalled
